| Literature DB >> 25853263 |
Kamilu M Karaye1,2, Isah A Yahaya3, Krister Lindmark4,5, Michael Y Henein6,7.
Abstract
The study aimed to determine if selenium deficiency, serum ceruloplasmin and traditional birth practices are risk factors for peripartum cardiomyopathy (PPCM), in Kano, Nigeria. This is a case-control study carried out in three hospitals, and PPCM patients were followed up for six months. Critically low serum selenium concentration was defined as <70 µg/L. A total of 39 PPCM patients and 50 controls were consecutively recruited after satisfying the inclusion criteria. Mean serum selenium in patients (61.7 ± 14.9 µg/L) was significantly lower than in controls (118.4 ± 45.6 µg/L) (p < 0.001). The prevalence of serum selenium <70 µg/L was significantly higher among patients (76.9%) than controls (22.0%) (p < 0.001). The mean ceruloplasmin and prevalence of socio-economic indices, multiparity, pregnancy-induced hypertension, obesity and twin pregnancy were not different between the groups (p > 0.05). Logistic regression showed that rural residency significantly increased the odds for serum selenium <70 µg/L by 2.773-fold (p = 0.037). Baseline serum levels of selenium and ceruloplasmin were not associated with six-month mortality. This study has shown that selenium deficiency is a risk factor for PPCM in Kano, Nigeria, and is related to rural residency. However, serum ceruloplasmin, customary birth practices and some other characteristics were not associated with PPCM in the study area.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25853263 PMCID: PMC4425040 DOI: 10.3390/ijms16047644
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Baseline characteristics of peripartum cardiomyopathy (PPCM) patients and controls.
| Variables | PPCM Patients
| Controls
| |
|---|---|---|---|
| Age, years | 25.9 ± 6.5 | 26.4 ± 6.2 | 0.674 |
| Body mass index, kg/m2 | 21.2 ± 3.9 | 21.9 ± 4.2 | 0.377 |
| Systolic blood pressure, mmHg | 119 ± 26 | 126 ± 18 | 0.124 |
| Diastolic blood pressure, mmHg | 86 ± 19 | 83 ± 14 | 0.469 |
| Hypotension (SBP | 13 (33.3%) | 2 (4%) | <0.001 * |
| Heart rate, beats/min | 108 ± 17 | 94 ± 16 | <0.001 * |
| Log10 Family income/month, ₦ | 4.31 ± 0.31 | 4.28 ± 0.37 | 0.672 |
| Log10 Education, years | 0.99 ± 0.21 | 0.97 ± 0.15 | 593 |
| NYHA class | |||
| I | 0 | 50 (100%) | <0.001 * |
| II | 14 (35.9%) | 0 | |
| III | 18 (46.2%) | 0 | |
| IV | 7 (18.0%) | 0 | |
| Hemoglobin, g/dL | 12.3 ± 1.8 | 13.4 ± 2.8 | 0.058 |
| Serum sodium, mmol/L | 136.0 ± 5.5 | 140.4 ± 4.1 | <0.001 * |
| Serum creatinine, µmol/L | 79.8 ± 21.9 | 73.3 ± 18.0 | 0.149 |
| Anemia | 16 (41.0%) | 11 (22.0%) | 0.053 |
| Serum albumin, g/dL | 32.4 ± 4.9 | 35.8 ± 7.3 | 0.061 |
| Log10 ALT | 1.17 ± 0.47 | 1.27 ± 0.29 | 0.305 |
| Log10 AST | 1.29 ± 0.40 | 1.43 ± 0.23 | 0.088 |
| ACEI or ARB | 18 (46.2%) | 0 | - |
| Digoxin | 37 (94.9%) | 0 | - |
| Beta-blockers | 3 (7.7%) | 0 | - |
| Spironolactone | 37 (94.9%) | 0 | - |
| Nifedipine | 0 | 7 (14.0%) | - |
| α-Methyl Dopa | 5 (12.8%) | 14 (28.0%) | 0.083 |
| Thiazide diuretic | 10 (25.6%) | 8 (16.0%) | 0.261 |
₦, Nigerian Naira; * p-value statistically significant; SBP, systolic blood pressure; NYHA, New York Heart Association; ALT, alanine transaminase; AST, aspartate transaminase; ACEI, Angiotensin Converting Enzyme Inhibitors; ARB, Angiotensin Receptor Blocker. Results are presented as means ± standard deviations, or as numbers with percentages in parentheses.
Profile of risk factors for peripartum cardiomyopathy among PPCM patients and controls.
| Variables | PPCM Patients
| Controls
| |
|---|---|---|---|
| Selenium, µg/L | 61.7 ± 14.9 | 118.4 ± 45.6 | <0.001 * |
| Selenium <70 µg/L | 30 (76.9%) | 11 (22.0%) | <0.001 * |
| Selenium <45 µg/L | 6 (15.4%) | 0 | - |
| Ceruloplasmin, mg/dL | 43.9 ± 15.8 | 45.3 ± 15.7 | 0.682 |
| Ceruloplasmin >60 mg/dL | 7 (18.0%) | 4 (8.0%) | 0.201 |
| Multiparity | 29 (74.4%) | 42 (84.0%) | 0.296 |
| Pregnancy-induced hypertension | 16 (41.0%) | 14 (28%) | 0.197 |
| Traditional hot baths | 14 (35.9%) | 41 (82%) | <0.001 * |
| “Kunun kanwa” | 9 (23.1%) | 39 (78%) | <0.001 * |
| Twin pregnancies | 2 (5.1%) | 2 (4.0%) | 0.799 |
| Rural residency | 18 (46.2%) | 7 (14.0%) | <0.001 * |
* p-Value statistically significant; Results are presented as means ± standard deviations, or as numbers with percentages in parentheses.
Baseline characteristics of patients alive and the deceased at six-month follow-up.
| Variables | Patients Alive
| Deceased
| |
|---|---|---|---|
| Selenium, µg/L | 63.3 ± 14.1 | 60.1 ± 13.5 | 0.634 |
| Ceruloplasmin, mg/dL | 49.1 ± 13.2 | 39.4 ± 10.8 | 0.127 |
| Age, years | 26.3 ± 5.9 | 26.0 ± 9.2 | 0.940 |
| NYHA class | |||
| II | 7 (41.2%) | 3 (50.0%) | 0.280 |
| III | 8 (47.1%) | 1 (16.7%) | |
| IV | 2 (11.8%) | 2 (33.3%) | |
| Systolic BP, mmHg | 112.8 ± 19.2 | 120.0 ± 32.3 | 0.525 |
| Diastolic BP, mmHg | 79.8 ± 14.6 | 91.7 ± 24.0 | 0.169 |
| Heart rate, beats/min | 107 ± 19 | 114 ± 13 | 0.379 |
| Log10 income | 4.4 ± 0.3 | 4.1 ± 0.1 | 0.003 * |
| BMI, Kg/m2 | 21.1 ± 4.9 | 21.3 ± 2.4 | 0.933 |
| Log10 creatinine | 1.86 ± 0.16 | 1.90 ± 0.15 | 0.622 |
| Hemoglobin, g/dL | 12.9 ± 1.4 | 13.0 ± 1.0 | 0.929 |
| LVEDDi, mm/m2 | 40.4 ± 5.4 | 41.4 ± 4.4 | 0.683 |
| LVEF, % | 33.3 ± 10.5 | 29.2 ± 12.8 | 0.446 |
| ARB/ACEI | 8 | 4 | 0.646 |
| Beta blockers | 1 | 1 | 0.481 |
| Spironolactone | 15 | 6 | 1.000 |
| Digoxin | 16 | 5 | 0.273 |
NYHA, New York Heart Association; BP, blood pressure; BMI, body mass index; LVEDDi, left ventricular end-diastolic dimension indexed to body surface area; LVEF, left ventricular ejection fraction; ARB, angiotensin II receptor blocker; ACEI, angiotensin converting enzyme inhibitor; * p-value statistically significant. Results are presented as means ± standard deviations, or as numbers with percentages in parentheses.